Hormone receptors in breast cancer

Publication date

2016-01-01

Authors

Suijkerbuijk, KarijnORCID 0000-0003-3604-5430ISNI 0000000388512483
van der Wall, ElskenORCID 0000-0003-2568-6937ISNI 0000000396428150
van Diest, PaulORCID 0000-0003-0658-2745ISNI 000000004213151X

Editors

Badve, Sunil
Gökmen-Polar, Yesim

Advisors

Supervisors

Document Type

Part of book

Collections

Open Access logo

License

taverne

Abstract

Steroid hormone receptors are critical for the growth and development of breast tissue as well as of breast cancer. The importance of the role estrogens in breast cancer has been delineated for more than 100 years. The analysis of its expression has been used not only to classify breast cancers but also for treating patients. The expression of ER and PR in tumors is associated with better prognosis and sensitivity to endocrine therapy. In this chapter we discuss the role of these receptors in addition to androgen receptor (AR) in breast cancer. A brief overview of the structure and function of these receptors and methods to detect their presence in breast cancer is presented. This includes criteria for scoring positivity and national and international guidelines associated with the scoring. Lastly, data regarding the use of expression of AR as therapeutic target, particularly in triple negative cancers, is presented.

Keywords

ASCO-CAP, Endocrine therapy, Estrogen, Progesterone and androgen receptors, Scoring, Taverne, General Medicine

Citation

Suijkerbuijk, K P M, van der Wall, E & van Diest, P J 2016, Hormone receptors in breast cancer. in S Badve & Y Gökmen-Polar (eds), Molecular Pathology of Breast Cancer. Springer International Publishing, pp. 45-58. https://doi.org/10.1007/978-3-319-41761-5_4